The Cytokinetics Scientific and Clinical Advisory Board members are thought leaders in the areas of cellular, developmental and molecular biology, physiology, chemistry, pharmacology, translational medicine, pharmaceutical development and regulatory affairs.
To see the members of each of our individual Scientific Advisory Boards listed below, please click on the details tab under the appropriate title.
SKELETAL MUSCLE Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director Basic Chemistry, Merck
Roger Cooke, Ph.D.
Professor, UCSF
Department of Biochemistry and BioPhysics
Roger Enoka, Ph.D.
Professor and Chairman, University of Colorado
Department of Integrative Physiology
John Faulkner. Ph.D.
Professor, University of Michigan
Department of Physiology
Lawrence Goldstein, Ph.D.
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator, UCSD
Department of Cellular and Molecular Medicine
Charles Homcy, M.D.
CEO, Portola Pharmaceuticals
Thomas Pollard, M.D.
Professor, Yale University
Department of Molecular, Cellular and Developmental Biology
Jeffrey Rothstein, M.D.
Professor, Johns Hopkins Medical School
Department of Neurology
John Solaro, Ph.D.
Distinguished University Professor, University of Illinois at Chicago
Department of Physiology and Biophysics
James Spudich, Ph.D.
Co-Founder and Director, Cytokinetics; Professor, Stanford School of Medicine
Department of Biochemistry
PULMONARY Details
Peter Barnes, DM, DSc, FRM, FMed
Professor, Imperial College of London
Department of Thoracic Medicine
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, Basic Chemistry, Merck
John Fahy, M.D.
Professor, UCSF
Division of Pulmonary and Critical Care Medicine and Division of Allergy and Immunology
Charles Homcy, M.D.
CEO, Portola Pharmaceuticals
Reynold Panettieri, Jr, M.D.
Professor, University of Pennsylvania Medical Center
Pulmonary, Allergy and Critical Care Division
Thomas Pollard, M.D.
Professor, Yale University
Department of Molecular, Cellular and Developmental Biology
Julian Solway, M.D.
Walter L. Palmer Distinguished Service Professor, University of Chicago
Department of Pulmonary and Critical Care
James Spudich, Ph.D.
Co-Founder and Director, Cytokinetics; Professor, Stanford School of Medicine
Department of Biochemistry
HYPERTENSION Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, Basic Chemistry, Merck
Charles Homcy, M.D.
CEO, Portola Pharmaceuticals
Thomas Pollard, M.D.
Professor, Yale University
Department of Molecular, Cellular and Developmental Biology
You-Tang Shen, M.D.
Professor and Director, University of Medicine and Dentistry of New Jersey
Department of Cell Biology and Molecular Medicine
James Spudich, Ph.D.
Co-Founder and Director, Cytokinetics; Professor, Stanford School of Medicine
Department of Biochemistry
John Teerlink, M.D.
Associate Professor, UCSF
Department of Cardiology
Stephen Vatner, M.D.
Professor and Chair, University of Medicine and Dentistry of New Jersey
Department of Cell Biology and Molecular Medicine
GLAUCOMA Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, Basic Chemistry, Merck
Paul Kaufman, M.D.
Professor and Chairman, The University of Wisconsin Madison
Department of Ophthalmology and Visual Sciences
Daniel Stamer, Ph.D.
Associate Chairman, University of Arizona
Department of Ophthalmology and Vision Science
Robert Weinreb, M.D.
Distinguished Professor; Chief, Glaucoma Director; Vice Chairman, UCSD Glaucoma Center/Shirley Eye Center
Department of Ophthalmology
HEART FAILURE Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, M.D., Merck
Charles Homcy, M.D.
CEO, Portola Pharmaceuticals
Thomas Pollard, M.D.
Professor, Yale University
Department of Molecular, Cellular and Developmental Biology
You-Tang Shen, M.D.
Professor and Director, University of Medicine and Dentistry of New Jersey
Department of Cell Biology and Molecular Medicine
John Solaro, Ph.D.
Distinguished University Professor, University of Illinois at Chicago
Department Physiology and Biophysics
James Spudich, Ph.D.
Co-Founder and Director, Cytokinetics; Professor, Stanford School of Medicine
Department of Biochemistry
John Teerlink, M.D.
Associate Professor, UCSF
Division of Cardiology
Stephen Vatner, M.D.
Professor and Chairman, University of Medicine and Dentistry of New Jersey
Department of Cell Biology and Molecular Medicine
ONCOLOGY Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, Basic Chemistry, Merck
Randall Johnson, Ph.D.
Independent Consultant
Tim Mitchison, Ph.D.
Professor, Harvard Medical School
Department of Systems Biology
Robert Orlowski, M.D.
Associate Professor of Medicine, UNC at Chapel Hill
Department of Pharmacology
Neal Rosen, M.D., Ph.D.
Professor, Memorial Sloan-Kettering Cancer Center
Departments of Molecular Pharmacology and Chemistry
Ronald Vale, Ph.D.
Co-Founder, Cytokinetics; Professor and Howard Hughes Investigator, UCSF
Department of Cellular and Molecular Biology
CHEMISTRY Details
John Chabala, Ph.D.
Former President and CSO, Pharmacopeia; Former VP, Discovery Chemistry, BMS; Former Executive Director, Basic Chemistry, Merck
Eric Gordon, Ph.D.
Scientific and Venture Consultant and Advisor, Palantir Consulting
Brian Stoltz, Ph.D.
Professor of Chemistry, California Institute of Technology
Department of Chemistry
